View source for Gail K. Naughton

'''Gail K. Naughton''', Ph.D., MBA, B.S., was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [https://www.takeda.com/newsroom/newsreleases/2019/takeda-completes-acquisition-of-shire-becoming-a-global-values-based-rd-driven-biopharmaceutical-leader/ Shire], a medical company based in Dublin, Ireland.

Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb
 |last=
 |first=
 |date=2012-09-05
 |title=U.S. Patent issued for Histogen's Novel Cell Growth Process
 |url=http://www.histogen.com/aboutus/news_events.htm#37
 |publisher=Histogen
 |accessdate=2012-11-16
}}</ref>
{{SEEALSO}}
* [[United States of America]]
{{LINKS}}
* {{REFweb
 |url=https://www.lji.org/team-member/gail-naughton-ph-d-mba/
 |title=Gail K. Naughton, Ph.D., MBA
 |last=
 |first=
 |init=
 |publisher=La Jolla Institute for Imunology
 |date=
 |accessdate=2024-05-02
}}
{{REF}}

{{DEFAULTSORT:Naughton, Gail K}}

[[Category:Person]]
[[Category:Female]]

[[Category:Financial gain]]

[[Category:From CircLeaks]]
[[Category:From IntactWiki]]

[[Category:USA]]

[[de:{{FULLPAGENAME}}]]